American Century Companies Inc. grew its stake in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 0.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,565,697 shares of the company's stock after buying an additional 14,250 shares during the period. American Century Companies Inc. owned 3.97% of ChampionX worth $205,711,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in CHX. Calamos Advisors LLC raised its stake in shares of ChampionX by 470.4% during the fourth quarter. Calamos Advisors LLC now owns 1,494,500 shares of the company's stock valued at $40,635,000 after purchasing an additional 1,232,500 shares during the period. Westchester Capital Management LLC boosted its stake in ChampionX by 67.8% during the 3rd quarter. Westchester Capital Management LLC now owns 2,828,139 shares of the company's stock valued at $85,268,000 after purchasing an additional 1,142,628 shares in the last quarter. Birnam Oak Advisors LP acquired a new position in ChampionX during the fourth quarter worth about $17,037,000. Oddo BHF Asset Management Sas bought a new stake in shares of ChampionX in the 3rd quarter worth approximately $15,075,000. Finally, Alpine Associates Management Inc. lifted its position in shares of ChampionX by 63.5% during the 4th quarter. Alpine Associates Management Inc. now owns 1,182,716 shares of the company's stock valued at $32,158,000 after acquiring an additional 459,200 shares during the last quarter. 98.99% of the stock is owned by institutional investors and hedge funds.
ChampionX Trading Down 0.7 %
Shares of CHX traded down $0.22 during midday trading on Thursday, hitting $30.15. The stock had a trading volume of 22,127,588 shares, compared to its average volume of 2,249,606. ChampionX Co. has a fifty-two week low of $25.57 and a fifty-two week high of $39.95. The company has a current ratio of 1.99, a quick ratio of 1.36 and a debt-to-equity ratio of 0.32. The firm has a market cap of $5.75 billion, a P/E ratio of 18.27 and a beta of 2.28. The business has a 50-day simple moving average of $29.45 and a two-hundred day simple moving average of $29.46.
ChampionX (NASDAQ:CHX - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.50 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.03. ChampionX had a net margin of 8.81% and a return on equity of 19.84%. As a group, equities analysts forecast that ChampionX Co. will post 1.92 EPS for the current year.
ChampionX Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, April 4th will be issued a dividend of $0.095 per share. This represents a $0.38 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date of this dividend is Friday, April 4th. ChampionX's dividend payout ratio (DPR) is 23.03%.
About ChampionX
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Recommended Stories

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.